Several studies have described that GPRC5A plays a role in tumor initiation by affecting the signal transducer and activator of the transcription 3 (STAT3) signaling pathway (Chen et al., 2010; Jahny et al., 2017; Liu et al., 2017; Zhong et al., 2015). This evidence concerns the gene STAT3 and neoplasm.